Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 8, Number 5—May 2002

Nasopharyngeal Carriage of Streptococcus pneumoniae in Healthy Children: Implications for the Use of Heptavalent Pnemococcal Conjugate Vaccine

Paola Marchisio*, Susanna Esposito*, Gian Carlo Schito†, Anna Marchese†, Roberta Cavagna*, Nicola Principi*Comments to Author , and the Hercules Project Collaborative Group
Author affiliations: *University of Milan, Milan, Italy; †University of Genoa, Genoa, Italy

Main Article

Table 3

Antibiotic resistance pattern of Streptococcus pneumoniae strains, 13 Italian cities, April 15–June 15, 2000

Antibiotic Resistant strains (%)
Penicillin 22 (9.1%)
Amoxicillin 0
Amoxicillin-clavulanate 0
Cefotaxime 9 (3.7)
Ceftriaxone 8 (3.3)
Meropenem 12 (4.9)
Azithromycin 126 (52.1)
Clarithromycin 126 (52.1)
Erythromycin 126 (52.1)
Tetracyclin 74 (30.6)
Thrimethoprim-sulphamethoxazole 58 (23.9)
Rifampicin 0
Chloramphenicol 26 (10.7)

Main Article

1The Hercules Project Collaborative Group includes: F. Schettini, D. De Mattia (Bari, Italy); G. P. Salvioli, G. Faldella (Bologna, Italy); G. Caramia, E. Ruffini (Ancona, Italy); E. Reali (Cinisello Balsamo, Italy); R. Longhi (Como, Italy); G. Bona (Novara, Italy); A. Guarino, F. Albano (Napoli, Italy); R. Malvicini (Fidenza, Italy); L. Ziino (Palermo, Italy); I. Barberi, T. Corona (Messina, Italy); P. Pusceddu (Cagliari, Italy); T. Meloni (Sassari, Italy); G. Saggese, and M. Migliaccio (Pisa, Italy).

Page created: April 18, 2012
Page updated: April 18, 2012
Page reviewed: April 18, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.